| |
| |
|
| Insider
Information: |
Boulding Mark Elliott |
| Relationship: |
|
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
92,389 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,106,118 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,389 |
|
|
| Total
Value |
$3,106,118 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
9
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -257.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
92,389 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
21,200 |
92,389 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2024-01-30 |
4 |
S |
$27.25 |
$21,637 |
D/D |
(794) |
71,189 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2024-01-09 |
4 |
S |
$29.01 |
$56,231 |
D/D |
(1,938) |
71,983 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2024-01-08 |
4 |
S |
$28.64 |
$41,729 |
D/D |
(1,457) |
73,921 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-04-17 |
4 |
AS |
$51.42 |
$3,183,830 |
D/D |
(61,923) |
75,378 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-04-17 |
4 |
OE |
$30.86 |
$1,910,944 |
D/D |
61,923 |
134,009 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-01-31 |
4 |
S |
$45.63 |
$37,050 |
D/D |
(812) |
75,378 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-01-11 |
4 |
S |
$44.36 |
$21,958 |
D/D |
(495) |
76,190 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-01-10 |
4 |
S |
$42.93 |
$25,330 |
D/D |
(590) |
76,685 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-01-09 |
4 |
S |
$41.66 |
$34,783 |
D/D |
(835) |
77,275 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
78,110 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-10-18 |
4 |
OE |
$30.86 |
$9,227 |
D/D |
299 |
61,399 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-10-18 |
4 |
AS |
$55.04 |
$16,462 |
D/D |
(299) |
61,110 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-10-17 |
4 |
AS |
$55.00 |
$363,110 |
D/D |
(6,602) |
61,110 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-10-17 |
4 |
OE |
$30.86 |
$203,738 |
D/D |
6,602 |
67,512 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-09-20 |
4 |
AS |
$55.00 |
$64,680 |
D/D |
(1,176) |
61,110 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-09-20 |
4 |
OE |
$30.86 |
$36,291 |
D/D |
1,176 |
61,410 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-04-05 |
4 |
AS |
$45.00 |
$225 |
D/D |
(5) |
61,110 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
EXEC. VP AND CLO |
• – – |
2022-04-05 |
4 |
OE |
$11.23 |
$56 |
D/D |
5 |
61,115 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2022-02-10 |
4 |
AS |
$45.03 |
$807,559 |
D/D |
(17,935) |
61,110 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2022-02-10 |
4 |
OE |
$11.23 |
$307,537 |
D/D |
17,935 |
76,763 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2022-02-01 |
4 |
S |
$40.00 |
$31,162 |
D/D |
(779) |
61,110 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
61,889 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2022-01-07 |
4 |
S |
$38.53 |
$34,095 |
D/D |
(885) |
47,489 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-09-02 |
4 |
AS |
$45.01 |
$151,375 |
D/D |
(3,363) |
48,374 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
